Atomi Financial Group Inc. Boosts Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Atomi Financial Group Inc. raised its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 71.5% in the 4th quarter, Holdings Channel.com reports. The institutional investor owned 2,337 shares of the medical equipment provider’s stock after buying an additional 974 shares during the period. Atomi Financial Group Inc.’s holdings in Intuitive Surgical were worth $1,220,000 at the end of the most recent quarter.

Other hedge funds have also added to or reduced their stakes in the company. Godsey & Gibb Inc. boosted its holdings in shares of Intuitive Surgical by 140.0% in the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock valued at $29,000 after purchasing an additional 35 shares during the period. MidAtlantic Capital Management Inc. bought a new stake in Intuitive Surgical during the 3rd quarter valued at $33,000. Decker Retirement Planning Inc. purchased a new stake in shares of Intuitive Surgical in the 4th quarter worth $36,000. Capital Performance Advisors LLP bought a new position in shares of Intuitive Surgical during the 3rd quarter worth $38,000. Finally, DT Investment Partners LLC increased its stake in shares of Intuitive Surgical by 80.0% during the third quarter. DT Investment Partners LLC now owns 81 shares of the medical equipment provider’s stock valued at $40,000 after buying an additional 36 shares during the period. 83.64% of the stock is currently owned by institutional investors.

Intuitive Surgical Trading Up 1.9 %

NASDAQ ISRG opened at $604.12 on Wednesday. The stock has a market cap of $215.18 billion, a P/E ratio of 97.13, a P/E/G ratio of 5.04 and a beta of 1.39. Intuitive Surgical, Inc. has a 12-month low of $362.14 and a 12-month high of $606.27. The company has a fifty day simple moving average of $541.80 and a two-hundred day simple moving average of $500.76.

Insider Buying and Selling

In related news, CFO Jamie Samath sold 270 shares of the stock in a transaction that occurred on Tuesday, December 10th. The shares were sold at an average price of $540.15, for a total value of $145,840.50. Following the transaction, the chief financial officer now owns 8,757 shares in the company, valued at approximately $4,730,093.55. This represents a 2.99 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Robert Desantis sold 188 shares of the firm’s stock in a transaction that occurred on Tuesday, October 29th. The stock was sold at an average price of $506.52, for a total transaction of $95,225.76. Following the transaction, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at $2,788,899.12. This represents a 3.30 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 43,509 shares of company stock worth $22,602,212 in the last 90 days. Insiders own 0.80% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages have issued reports on ISRG. Piper Sandler reiterated an “overweight” rating and set a $538.00 target price (up from $495.00) on shares of Intuitive Surgical in a report on Friday, October 18th. Leerink Partners lifted their price objective on shares of Intuitive Surgical from $489.00 to $502.00 in a report on Thursday, October 17th. Erste Group Bank upgraded Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Tuesday, November 19th. Raymond James lifted their price target on Intuitive Surgical from $500.00 to $540.00 and gave the company an “outperform” rating in a report on Monday, October 14th. Finally, BTIG Research upped their price objective on Intuitive Surgical from $535.00 to $561.00 and gave the stock a “buy” rating in a research note on Tuesday, November 26th. One analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $554.17.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.